NCT07563387
taVNS for Speech and Language Recovery in Aphasia
Enrolling by Invitation
NAAges 18–80InterventionalTreatmentUniversity of FloridaInvestigator-initiated
~12 participants
Updated 2026-05-04 on ClinicalTrials.gov
What's tested:taVNSsham taVNS
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adverse events
Measured over 6 months
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adults between 18-80
Native speakers of English or simultaneous bilinguals
At least 6 months post stroke or TBI
Diagnosed production type aphasia or apraxia of speech
Exclusion
Additional cognitive or neurological impairments (Autism, schizophrenia, seizures, etc)
Language comprehension deficits
Medications that influence key neurotransmitters
What this trial measures
- Adverse events6 months
Frequency and severity of adverse events will be monitored and evaluated for severity and impact on attrition.
- Compliance6 months
Percentage of the population that remains engaged in the study and completes all stimulation sessions.